Product image of Zejula (Niraparib) supplied by GNH India

Zejula

Active Ingredient:
Niraparib
Origin:
EU

Zejula (Niraparib)

Zejula (niraparib) is an oral prescription medication used in cancer care. It belongs to the PARP inhibitor class, supporting targeted therapy approaches. This page provides neutral, factual details about its use and handling. Always consult a healthcare provider for personalized guidance.

Manufacturer / TM Owner

Glaxosmithkline (Ireland) Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Zejula is primarily used in the treatment of certain types of ovarian cancer, including maintenance therapy after response to platinum-based chemotherapy. It is also utilized in select cases of fallopian tube or peritoneal cancer. Patients and caregivers often ask, 'what is niraparib used for' to understand its role in cancer management. Its mechanism supports DNA repair inhibition in cancer cells.

Side Effects

  • As with many medications, niraparib may cause effects such as fatigue, nausea, or digestive changes. Some individuals report dizziness or headaches during treatment. These effects vary by person and are typically monitored by a healthcare team. Regular check-ins help manage any concerns that arise.

Precautions & Warnings

  • Niraparib should be handled with care, especially by those with known allergies to its components. Blood counts are often monitored due to potential effects on bone marrow. Patients are advised to report any unusual symptoms promptly. Keep this medication stored securely, away from children and pets.

Avoid Interactions

  • Niraparib may interact with other medications, including certain antidepressants, antifungals, or blood thinners. Strong CYP3A4 inhibitors or inducers can alter its levels in the body. Alcohol use may intensify side effects like drowsiness. Always disclose all medications and supplements to your healthcare provider before starting niraparib.

Frequently Asked Questions

Niraparib is used in the treatment of certain ovarian, fallopian tube, or peritoneal cancers, often as maintenance therapy.

Niraparib is an oral medication, typically taken once daily with or without food, as directed by a healthcare provider.

Common effects may include fatigue, nausea, digestive changes, dizziness, or headaches. These should be discussed with a doctor.

Niraparib may interact with other drugs, including CYP3A4 inhibitors or inducers. Always consult your healthcare provider before combining medications.

Niraparib may cause harm to an unborn baby. Use effective birth control during treatment and discuss family planning with your doctor.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Niraparib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT